| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.310 | 4.770 | 6.902 | 7.310 | 5.581 | 4.791 | 4.226 |
| Total Income - EUR | - | - | - | 3.360 | 4.770 | 6.902 | 7.310 | 5.581 | 4.791 | 4.226 |
| Total Expenses - EUR | - | - | - | 2.658 | 1.936 | 2.496 | 2.438 | 2.700 | 2.551 | 4.514 |
| Gross Profit/Loss - EUR | - | - | - | 701 | 2.834 | 4.406 | 4.872 | 2.882 | 2.240 | -289 |
| Net Profit/Loss - EUR | - | - | - | 602 | 2.691 | 4.205 | 4.657 | 2.739 | 1.739 | -383 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Compania Medicala Dr. Pompilian Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 2.029 | 3.883 | 8.093 | 12.575 | 13.971 | 9.413 | 7.719 |
| Inventories | - | - | - | 111 | 328 | 322 | 315 | 997 | 994 | 0 |
| Receivables | - | - | - | 485 | 800 | 1.458 | 370 | 509 | 1.655 | 1.504 |
| Cash | - | - | - | 1.434 | 2.754 | 6.313 | 11.890 | 12.465 | 6.764 | 6.215 |
| Shareholders Funds | - | - | - | 848 | 3.523 | 7.661 | 12.148 | 13.645 | 8.750 | 7.297 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.181 | 360 | 431 | 426 | 326 | 663 | 422 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Compania Medicala Dr. Pompilian Srl